Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Conditions:   Chagas Disease;   Heart Failure Interventions:   Drug: Sacubitril/valsartan;   Drug: Enalapril Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - July 17, 2019 Category: Research Source Type: clinical trials